Ep 19. Johan Bengtsson Palme & AMR in the environment. Colistin pharmacokinetics. AB use in LMIC.
We welcome the summer at The AMR Studio! This month, we bring you a deep conversation with Dr. Johan Bengtsson Palme from the CARe center in Gothenburg about the role of the environment in the AMR problem and how his group focuses on studying it. Dive deep into this essential part of "one health" that is so frequently talked about. In the news, we feature two recent UAC articles! Our PhD student Viktor Rognås has published his work on understanding the pharmacokinetics of colistin in very sick patients, while our PhD student Gbemisola Allwell-Brown has published her first article looking into the trends of antibiotic use in 73 low- & middle-income countries. Congrats guys! We hope you enjoy this episode and see you again in July!
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
or you can listen to our nineteenth episode right here:
- Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. First article covered in the news, by UAC PhD student Viktor Rognås.
- Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005–17: a systematic analysis of 132 national surveys from 73 countries. Second article covered in the news, by UAC PhD student Gbemisola Allwell-Brown.
- Measuring antibiotic use in children: piecing together the puzzle. Comment on The Lancet Global Health about Gbemisola's article.
- Class II contact‐dependent growth inhibition (CDI) systems allow for broad‐range cross‐species toxin delivery within the Enterobacteriaceae family. Last article mentioned in the news, by UAC PhD student Petra Virtanen.